Background illustration for clinical trials search

Paid Clinical Trials Springfield

Discover 192 paid clinical trials in Springfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

for
COVID-19 SARS-CoV-2 Infection
Location: Morton IL, Louisville KY, Columbus OH, Papillion NE,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT06679140

Phase3, Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Morton IL, Hazelwood MO, Chesterfield MO, Oak Lawn IL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase2, Recruiting

INTEGRATED CHILDHOOD ACTIVITY AND NUTRITION (ICAN) STUDY

for
Achievement, Weight Change, Cognition, Fitness,
Location: Bloomington IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 6 - 11

Code: NCT07011602

Recruiting

Consistently Assess Signs and Symptom of Heart Failure

for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Normal IL
Sponsor: Board of Trustees of Illinois State University

Sex: All

Age: 18 - 70+

Code: NCT05833581

Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase2, Recruiting

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Normal IL, Effingham IL, Mattoon IL, Urbana IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase2, Recruiting

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

for
Cancer
Location: Normal IL, Bloomington IL, Effingham IL, Mattoon IL,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18+

Code: NCT06756607

Recruiting
Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Springfield IL, Peoria IL, St Louis MO, Columbia MO,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Springfield IL, Dyer IN, Des Moines IA, Kansas City MO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: Springfield IL, Peoria IL, St. Louis MO, Iowa City IA,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase3, Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Decatur IL, Kansas City MO, Canton OH, Sioux Falls SD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting